MediSpheresTechnology. For purposes of this Supplemental Agreement and the 1999 Agreements, MediSpheres™ Technology shall mean (i) the method of manufacturing stable, dry metal ion-lipid microparticle compositions for drug delivery based on the formation of a lipid-metal ion complex matrix that incorporates the drug or active agent to be delivered, and (ii) the microparticle compositions manufactured by such method, both as further described in [CONFIDENTIAL TREATMENT REQUESTED] as well as its related
... continuation-in-part [CONFIDENTIAL TREATMENT REQUESTED] , and (iii) all foreign counterpart patent applications and patents claiming priority of such patent applications and patents, and (iv) all patents that have issued or in the future issue from any of the foregoing patent applications, including utility, model, and design patents and certificates of invention, and (v) all divisionals, continuations, continuations-in-part, reissues, reexaminations, renewals, extensions or additions of any of the foregoing patent applications and patents (the "MediSpheres™ Assigned Patent Rights"). The Parties have specifically agreed that all particles described in the MediSpheres™Assigned Patent Rights regardless of their particular microstructure, physical characteristics, or morphology are covered by the phrase MediSpheres™Technology.
View More
